Ocular Therapeutix, Inc. (OCUL)
NASDAQ·Healthcare·Biotechnology
$6.18
-7.05%
Mkt Cap $1.53B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (14 analysts)
$27.50
Range $25.00 – $30.00
Implied Upside
+345.3%
Consensus $27.50 vs current $6.18
NASDAQ·Healthcare·Biotechnology
$6.18
-7.05%
Mkt Cap $1.53B
Buy
9
Hold
0
Sell
0
Price Target (14 analysts)
$27.50
Range $25.00 – $30.00
+345.3%
Consensus $27.50 vs current $6.18